Petricoin et al. analysed blood proteins of women with ovarian cancer using mass spectroscopy and a novel computer-searching algorithm. They found a discriminatory proteomic pattern that correctly identified all 50 ovarian cancer cases and 63 of the 66 non-cancer cases from a set of 116 masked serum samples (sensitivity 100%; specificity 95%; positive predictive value 94%; Lancet 2002, 359:572-577).
"These findings justify a prospective population-based assessment of proteomic pattern technology, as a screening tool for all stages of ovarian cancer in high-risk and general populations," commented Emanuel Petricoin III.
